drugset / Trial / NCT02593968

Yallaferon in Chinese Population

NCT02593968 ↗

Phase 2 Unknown 100 enrolled Lee's Pharmaceutical Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of Yallaferon in Chinese population with HPV-16 and/or HPV-18.

Timeline

Start
2015-09
Primary completion
2016-09
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Recombinant Human Interferon a-2b Protein / enzyme biologic — —